Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study

with No hi ha comentaris

Hernández-Sánchez, D., Leyva-Moral, J. M., Olalla, J., & Negredo, E. (2025). Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study. Viruses, 17(7). https://doi.org/10.3390/v17070993

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *